Table 1 Demographics and clinical characteristics of COVID-19 survivors and controls in Session 1.
Characteristics | Session 1 | |
|---|---|---|
Covid-19 survivors | Controls | |
Age (years, SD) | 52.4 ± 13.5 | 52.0 ± 13.3 |
Sex (female/male) | 86/40 | 86/40 |
Clinical records (n, %) | 126, 100% | |
Fever (n, %) | 81, 64% | |
Cough (n, %) | 69, 55% | |
Hospitalization duration (days) | 12.6 ± 5.0 | |
Underlying diseases, (n %) | ||
Hypertension | 29, 23% | |
Diabetes | 8, 6% | |
Clinical type (n, %) | ||
Mild type | 117, 93% | |
Severe type | 9, 7% | |
Critical type | 0, 0% | |
Treatment (n, %) | ||
Oxygen therapy | 26, 21% | |
Anti-viral therapy | 81, 64% | |
Potential exposure (n, %) | ||
Close people had Covid-19 | 74, 59% | 15, 12% |
Received intensive care | 12, 10% | 0, 0% |
Witnessed death | 33, 26% | 2, 2% |
Witnessed others receive intensive care | 32, 25% | 2, 2% |
Hopeless feeling | 92, 73% | 37, 29% |
